Patents by Inventor Shirley Y. Lynn

Shirley Y. Lynn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reduced cortisol conjugates
    Patent number: 6383766
    Abstract: The present invention relates to compositions comprising novel reduced cortisol conjugates, methods for their preparation and use in immunoassays for cortisol. In another aspect, it relates to conjugates of reduced cortisol as immunogens or haptens for eliciting anti-cortisol or anti-reduced cortisol antibodies.
    Type: Grant
    Filed: September 30, 1999
    Date of Patent: May 7, 2002
    Assignee: Ortho-Clinical Diagnostics, Inc.
    Inventors: Harold C. Warren, Brian A. Snyder, Lisa D. Sprague, Shirley Y. Lynn, Paul B. Contestable, Holly L. Groth
  • Composition, analytical element and method for the quantification of creatine kinase
    Patent number: 4547461
    Abstract: An enzymatic method for the analytical determination of creatine kinase in an aqueous liquid such as blood serum is described. The determination is made by measuring an optical density change using the reagents creatine phosphate, adenosine diphosphate, glycerol, glycerol kinase, .alpha.-glycerophosphate oxidase, a chromagen and a mercapto-containing creatine kinase activator. The mercapto-containing creatine kinase activator is added in encapsulated form or in low concentrations so as to preserve the activity of the chromagen.
    Type: Grant
    Filed: January 18, 1983
    Date of Patent: October 15, 1985
    Assignee: Eastman Kodak Company
    Inventors: Theodore W. Esders, Shirley Y. Lynn, John B. Findlay, Richard M. Schubert
  • Process for the recovery of intracellular enzyme
    Patent number: 4275166
    Abstract: A process for the recovery of an intracellular enzyme from an aerobic soil microorganism is disclosed. The recovery method is carried out by(a) forming an aqueous suspension of microbial cells containing the desired intracellular enzyme,(b) disrupting the microbial cells in the suspension to release the enzyme from the cells, and(c) before, during, or after step (b) and prior to removal of disrupted microbial cells and other cellular components, introducing a water-miscible organic solvent into the suspension to form a mixture of the organic solvent and the enzyme-containing suspension.The desired enzyme is retained in the liquid phase of the mixture formed in step (c) while undesired cellular components such as other microbial cell proteins precipitate therefrom.
    Type: Grant
    Filed: November 5, 1979
    Date of Patent: June 23, 1981
    Assignee: Eastman Kodak Company
    Inventors: George T. McCollough, Theodore W. Esders, Shirley Y. Lynn
  • Stabilizers for reconstituted, lyophilized samples
    Patent number: 4127502
    Abstract: A serum matrix or serum-derived composition which, after lyophilization and reconstitution, has a reduced optical density, evidencing improved homogeneity.
    Type: Grant
    Filed: June 10, 1977
    Date of Patent: November 28, 1978
    Assignee: Eastman Kodak Company
    Inventors: Charles M. Li Mutti, Tai-Wing Wu, Shirley Y. Lynn